Overview

Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.

Status:
Completed

Trial end date:
2016-08-08

Target enrollment:

Participant gender:

Summary

To evaluate antihypertensive efficacy and tolerability of Nifedipine GITS 60mg treated for 8 weeks in Chinese hypertensive subjects who failed to achieve BP control with the starting-dose antihypertensive monotherapy.

Phase:

Phase 4

Details

Lead Sponsor:

Bayer

Treatments:

Nifedipine